Please enable JavaScript to continue using this application.

Compare $ALEC vs $SION | Chartloom

Compare

$ALEC vs $SION

Alector Inc · Sionna Therapeutics Inc

ALEC

Alector Inc

SION

Sionna Therapeutics Inc

Compare $ALEC vs $SION

Comparing Alector Inc and Sionna Therapeutics Inc

ALECAlector Inc

SIONSionna Therapeutics Inc

ALECAlector Inc

Market cap

$231M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

34.29x

Rev growth (TTM)

-82.9%

YTD performance

35.9%

52W performance

-32.5%

FCF yield

-68.6%

SIONSionna Therapeutics Inc

Market cap

$221M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-87.5%

52W performance

-82.8%

FCF yield

-34.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALEC

SION

Detailed metrics comparison

ALEC

Alector Inc

SION

Sionna Therapeutics Inc

Market Cap

ALEC$231M

SION$221M

Enterprise Value

ALEC$181M

SION$158M

Price

ALEC$2.08

SION$4.90

P/E Ratio

ALECN/A

SIONN/A

P/S Ratio

ALEC16.66x

SION0.00x

EV/Sales

ALEC13.05x

SION0.00x

EV/EBITDA

ALEC3.60x

SION0.00x

P/B Ratio

ALEC19.47x

SION0.84x

P/FCF Ratio

ALECN/A

SIONN/A

EV/FCF

ALEC-1.14x

SION-2.07x

PEG Ratio

ALECN/A

SIONN/A

Forward P/E (NTM)

ALECN/A

SIONN/A

Forward P/S (NTM)

ALEC34.29x

SIONN/A

Revenue (TTM)

ALEC$14M

SION$0

Revenue Growth (YoY)

ALEC-82.9%

SIONN/A

Forward Rev Growth

ALEC281.0%

SION1297.1%

Gross Margin (TTM)

ALEC0.0%

SION0.0%

Operating Margin (TTM)

ALEC0.0%

SION0.0%

EBITDA Margin (TTM)

ALEC-879.7%

SION0.0%

Net Margin (TTM)

ALEC-850.1%

SION0.0%

FCF Margin (TTM)

ALEC-1142.6%

SIONN/A

Net Income (TTM)

ALEC$-118M

SION$-97M

FCF (TTM)

ALEC$-158M

SION$-76M

EPS (TTM)

ALEC-$1.06

SION-$2.16

ROE (TTM)

ALEC-29517.0%

SION-3294.0%

ROA (TTM)

ALEC-4400.0%

SION-3108.0%

ROIC (TTM)

ALEC-24053.0%

SION-3294.0%

Cash

ALEC$60M

SION$63M

Debt

ALEC$10M

SION$0

Net Cash/Debt

ALEC$50M

SION$63M

Current Ratio (TTM)

ALEC5.26x

SION20.05x

Quick Ratio (TTM)

ALEC5.05x

SION19.57x

Debt/Equity (TTM)

ALEC0.94x

SION0.00x

Debt/Assets (TTM)

ALEC0.0%

SION0.0%

Interest Coverage (TTM)

ALECN/A

SIONN/A

Net Debt/EBITDA (TTM)

ALEC0.00x

SION0.00x

Beta

ALEC0.65

SION1.44

52W Performance

ALEC-32.5%

SION-82.8%

YTD Performance

ALEC35.9%

SION-87.5%

% from 52W High

ALEC-38.8%

SION-91.1%

% from 52W Low

ALEC90.8%

SION22.2%

Asset Turnover (TTM)

ALEC0.05x

SION0.00x

FCF Yield (TTM)

ALEC-68.6%

SION-34.4%

Earnings Yield (TTM)

ALEC-51.0%

SION-44.0%

Dividend Yield (TTM)

ALECN/A

SIONN/A

Rule of 40

ALEC-1,225.5

SION0.0

EV/GP/RG

ALECN/A

SIONN/A

Ticker research

View ALEC research View SION research

Metric	ALEC Alector Inc	SION Sionna Therapeutics Inc
Market & Valuation
Market Cap	$231M	$221M
Enterprise Value	$181M	$158M
Price	$2.08	$4.90
P/E Ratio	N/A	N/A
P/S Ratio	16.66x	0.00x
EV/Sales	13.05x	0.00x
EV/EBITDA	3.60x	0.00x
P/B Ratio	19.47x	0.84x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.14x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	34.29x	N/A
Revenue & Growth
Revenue (TTM)	$14M	$0
Revenue Growth (YoY)	-82.9%	N/A
Forward Rev Growth	281.0%	1297.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-879.7%	0.0%
Net Margin (TTM)	-850.1%	0.0%
FCF Margin (TTM)	-1142.6%	N/A
Net Income (TTM)	$-118M	$-97M
FCF (TTM)	$-158M	$-76M
EPS (TTM)	-$1.06	-$2.16
ROE (TTM)	-29517.0%	-3294.0%
ROA (TTM)	-4400.0%	-3108.0%
ROIC (TTM)	-24053.0%	-3294.0%
Financial Health
Cash	$60M	$63M
Debt	$10M	$0
Net Cash/Debt	$50M	$63M
Current Ratio (TTM)	5.26x	20.05x
Quick Ratio (TTM)	5.05x	19.57x
Debt/Equity (TTM)	0.94x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.65	1.44
52W Performance	-32.5%	-82.8%
YTD Performance	35.9%	-87.5%
% from 52W High	-38.8%	-91.1%
% from 52W Low	90.8%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.00x
FCF Yield (TTM)	-68.6%	-34.4%
Earnings Yield (TTM)	-51.0%	-44.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,225.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALEC research	View SION research

Valuation

P/S Ratio

SION

0.00x

ALEC

16.66x

EV/FCF

SION

-2.07x

ALEC

-1.14x

Growth & revenue

Revenue Growth TTM

ALEC

-82.9%

Forward Revenue Growth

SION

1297.1%

ALEC

281.0%

Profitability & performance

Gross Margin

ALEC

0.0%

SION

0.0%

ROE

SION

-3294.0%

ALEC

-29517.0%

FCF Yield %

SION

-34.4%

ALEC

-68.6%

52-Week Performance

ALEC

-32.5%

SION

-82.8%

Detailed metrics comparison

ALEC

Alector Inc

SION

Sionna Therapeutics Inc

Market Cap

ALEC$231M

SION$221M

Enterprise Value

ALEC$181M

SION$158M

Price

ALEC$2.08

SION$4.90

P/E Ratio

ALECN/A

SIONN/A

P/S Ratio

ALEC16.66x

SION0.00x

EV/Sales

ALEC13.05x

SION0.00x

EV/EBITDA

ALEC3.60x

SION0.00x

P/B Ratio

ALEC19.47x

SION0.84x

P/FCF Ratio

ALECN/A

SIONN/A

EV/FCF

ALEC-1.14x

SION-2.07x

PEG Ratio

ALECN/A

SIONN/A

Forward P/E (NTM)

ALECN/A

SIONN/A

Forward P/S (NTM)

ALEC34.29x

SIONN/A

Revenue (TTM)

ALEC$14M

SION$0

Revenue Growth (YoY)

ALEC-82.9%

SIONN/A

Forward Rev Growth

ALEC281.0%

SION1297.1%

Gross Margin (TTM)

ALEC0.0%

SION0.0%

Operating Margin (TTM)

ALEC0.0%

SION0.0%

EBITDA Margin (TTM)

ALEC-879.7%

SION0.0%

Net Margin (TTM)

ALEC-850.1%

SION0.0%

FCF Margin (TTM)

ALEC-1142.6%

SIONN/A

Net Income (TTM)

ALEC$-118M

SION$-97M

FCF (TTM)

ALEC$-158M

SION$-76M

EPS (TTM)

ALEC-$1.06

SION-$2.16

ROE (TTM)

ALEC-29517.0%

SION-3294.0%

ROA (TTM)

ALEC-4400.0%

SION-3108.0%

ROIC (TTM)

ALEC-24053.0%

SION-3294.0%

Cash

ALEC$60M

SION$63M

Debt

ALEC$10M

SION$0

Net Cash/Debt

ALEC$50M

SION$63M

Current Ratio (TTM)

ALEC5.26x

SION20.05x

Quick Ratio (TTM)

ALEC5.05x

SION19.57x

Debt/Equity (TTM)

ALEC0.94x

SION0.00x

Debt/Assets (TTM)

ALEC0.0%

SION0.0%

Interest Coverage (TTM)

ALECN/A

SIONN/A

Net Debt/EBITDA (TTM)

ALEC0.00x

SION0.00x

Beta

ALEC0.65

SION1.44

52W Performance

ALEC-32.5%

SION-82.8%

YTD Performance

ALEC35.9%

SION-87.5%

% from 52W High

ALEC-38.8%

SION-91.1%

% from 52W Low

ALEC90.8%

SION22.2%

Asset Turnover (TTM)

ALEC0.05x

SION0.00x

FCF Yield (TTM)

ALEC-68.6%

SION-34.4%

Earnings Yield (TTM)

ALEC-51.0%

SION-44.0%

Dividend Yield (TTM)

ALECN/A

SIONN/A

Rule of 40

ALEC-1,225.5

SION0.0

EV/GP/RG

ALECN/A

SIONN/A

Ticker research

View ALEC research View SION research

Metric	ALEC Alector Inc	SION Sionna Therapeutics Inc
Market & Valuation
Market Cap	$231M	$221M
Enterprise Value	$181M	$158M
Price	$2.08	$4.90
P/E Ratio	N/A	N/A
P/S Ratio	16.66x	0.00x
EV/Sales	13.05x	0.00x
EV/EBITDA	3.60x	0.00x
P/B Ratio	19.47x	0.84x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.14x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	34.29x	N/A
Revenue & Growth
Revenue (TTM)	$14M	$0
Revenue Growth (YoY)	-82.9%	N/A
Forward Rev Growth	281.0%	1297.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-879.7%	0.0%
Net Margin (TTM)	-850.1%	0.0%
FCF Margin (TTM)	-1142.6%	N/A
Net Income (TTM)	$-118M	$-97M
FCF (TTM)	$-158M	$-76M
EPS (TTM)	-$1.06	-$2.16
ROE (TTM)	-29517.0%	-3294.0%
ROA (TTM)	-4400.0%	-3108.0%
ROIC (TTM)	-24053.0%	-3294.0%
Financial Health
Cash	$60M	$63M
Debt	$10M	$0
Net Cash/Debt	$50M	$63M
Current Ratio (TTM)	5.26x	20.05x
Quick Ratio (TTM)	5.05x	19.57x
Debt/Equity (TTM)	0.94x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.65	1.44
52W Performance	-32.5%	-82.8%
YTD Performance	35.9%	-87.5%
% from 52W High	-38.8%	-91.1%
% from 52W Low	90.8%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.00x
FCF Yield (TTM)	-68.6%	-34.4%
Earnings Yield (TTM)	-51.0%	-44.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,225.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALEC research	View SION research